Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -19.99% | -19.17% | -9.42% | -9.14% | -3.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.99% | -19.17% | -9.42% | -9.14% | -3.47% |
| Cost of Revenue | -18.32% | -19.11% | -2.20% | -0.23% | 7.91% |
| Gross Profit | -21.16% | -19.20% | -13.73% | -14.76% | -10.10% |
| SG&A Expenses | -36.30% | -33.64% | -34.55% | -45.29% | 0.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.03% | -22.47% | -12.59% | -14.11% | 5.27% |
| Operating Income | -12.22% | -13.43% | -4.41% | -2.37% | -16.77% |
| Income Before Tax | -12.59% | -18.58% | -6.27% | -10.27% | -10.45% |
| Income Tax Expenses | -27.19% | -22.02% | -6.96% | -29.44% | -20.11% |
| Earnings from Continuing Operations | -9.45% | -17.79% | -6.12% | -5.91% | -8.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.45% | -17.79% | -6.12% | -5.91% | -8.06% |
| EBIT | -12.22% | -13.43% | -4.41% | -2.37% | -16.77% |
| EBITDA | -25.90% | -26.53% | -19.64% | -11.34% | -11.96% |
| EPS Basic | -5.52% | -15.54% | -5.86% | -5.84% | -8.16% |
| Normalized Basic EPS | -5.89% | -8.69% | 0.66% | 6.72% | -4.75% |
| EPS Diluted | -5.56% | -14.97% | -6.03% | -5.84% | -8.32% |
| Normalized Diluted EPS | -5.63% | -8.42% | 0.88% | 6.72% | -4.77% |
| Average Basic Shares Outstanding | -4.17% | -2.66% | -0.28% | -0.07% | 0.11% |
| Average Diluted Shares Outstanding | -4.42% | -2.94% | -0.50% | -0.07% | 0.12% |
| Dividend Per Share | 1.69% | 1.69% | 1.69% | 1.69% | 1.72% |
| Payout Ratio | 0.08% | 0.23% | 0.08% | 0.08% | 0.11% |
